Drugs / Z20063878
last change Aug 2026 re-read 3 minutes ago

Z20063878

Developed for
ischemic stroke
Investigated by
Tongji Hospital

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT06883110 Sep 2025 → Aug 2026 overdue ischemic stroke Tongji Hospital Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Z20063878 ClinicalTrials.gov intervention name — accepted as the source's own label NCT06883110 ↗
Known as Angong Niuhuang Pills “Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd. Angong Niuhuang Pills (3g once daily as a single dose) for 7 consecutive days.” NCT06883110 ↗
Known as Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd. Angong Niuhuang Pills “Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd. Angong Niuhuang Pills (3g once daily as a single dose) for 7 consecutive days.” NCT06883110 ↗